A Retrospective Cohort Study of Cobra Envenomation: Clinical Characteristics, Treatments, and Outcomes
Toxins · 20.07.2023 · 15 (7) · 468
DOI: 10.3390/toxins15070468 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Toxins, online erschienen am 20.07.2023. Verfasst von Phantakan Tansuwannarat und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10540, Thailand. Hauptthemen laut MEDLINE: Elapidae, Snake Bites. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study investigated the clinical characteristics, treatments, and outcomes of envenomation involving cobra species in Thailand (Naja kaouthia, Naja siamensis, and Naja sumatrana). Data of patients who had been bitten by a cobra or inoculated via the eyes/skin in 2018–2021 were obtained from the Ramathibodi Poison Center. There were 1045 patients admitted during the 4-year study period (bite, n = 539; ocular/dermal inoculation, n = 506). Almost all patients with ocular/dermal inoculation had eye involvement and ocular injuries, but none had neurological effects. Most of the patients bitten by a cobra had local effects (69.0%) and neurological signs and symptoms (55.7%). The median interval between the bite and the onset of neurological symptoms was 1 h (range, 10 min to 24 h). Accordingly, patients should be observed closely in hospitals for at least 24 h after a bite. Intubation with ventilator support was required in 45.5% of patients and for a median duration of 1.1 days. Antivenom was administered in 63.5% of cases. There were nine deaths, most of which resulted from severe infection. Neurological effects and intubation were significantly more common after a monocled cobra bite than after a spitting cobra bite. The administration of antivenom with good supportive care, including the appropriate management of complications, especially wound infection, might decrease fatality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10540, Thailand.
- Ramathibodi Poison Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
- Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
- Department of Emergency Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
ORCID-Profile: Charuwan Sriapha
Zitieren
APA
Tansuwannarat, P., Tongpoo, A., Phongsawad, S., Sriapha, C., Wananukul, W., & Trakulsrichai, S. (2023). A Retrospective Cohort Study of Cobra Envenomation: Clinical Characteristics, Treatments, and Outcomes. Toxins, 15(7), 468. https://doi.org/10.3390/toxins15070468
Vancouver
Tansuwannarat P, Tongpoo A, Phongsawad S, Sriapha C, Wananukul W, Trakulsrichai S. A Retrospective Cohort Study of Cobra Envenomation: Clinical Characteristics, Treatments, and Outcomes. Toxins. 2023;15(7):468. doi:10.3390/toxins15070468
BibTeX
@article{Tansuwannarat2023,
author = {Tansuwannarat, Phantakan and Tongpoo, Achara and Phongsawad, Suraphong and Sriapha, Charuwan and Wananukul, Winai and Trakulsrichai, Satariya},
title = {A Retrospective Cohort Study of Cobra Envenomation: Clinical Characteristics, Treatments, and Outcomes},
journal = {Toxins},
year = {2023},
volume = {15},
number = {7},
pages = {468},
doi = {10.3390/toxins15070468}
}
EUVIMED